N,N'-二-[5-甲氧基-3-溴-2(5H)-4-呋喃酮基]-1,2-乙二胺的合成及其晶体结构(英文)

通过串联迈克尔加成-消除反应合成了N,N'-二-[5-甲氧基-3-溴-2(5H)-4-呋喃酮基]-1,2-乙二胺,利用IR、UV、1H NMR、13C NMR、MS、元素分析和X射线单晶衍射对其进行表征.X射线单晶衍射结果表明:标题化合物包含两个平面的呋喃酮环和两个手性中心,并通过N(1)-H(1A)…O(1)分子间氢键和Br(1)…O(2)近距离作用形成超分子结构.     

Zur Oxydation intermetallischer Phasen: Die Oxoplumbate(II) K6[Pb2O5] [1] und K4[PbO3] [2]

On the Oxidation of Intermetallic Phases: The Oxoplumbates(II) K₆[Pb₂O₅] [1] and K₄[PbO₃] [2] Very pale yellow crystals of K₆[Pb₂O₅] were obtained by heating a wellground mixture of LiPb und K₂O₂ (K₂O₂: LiPb = 2.5:1) in Ag-tubes (550°C; 40 d). The crystal structure, triclinic, space group P1 , a = 1 326.7(6); b = 758.8(4); c = 637.0(3) pm; α = 92.17(3)°; β = 94.41(3)°; γ = 112.85(4)°; Z = 2 was determined (four-circle diffractometer data, Mo? K, 3 270 I_o(hkl), R = 8.0%, R_w = 3.5%, parameters see text). The pale yellow crystals of K₄[PbO3] were received by heating KPb and K₂O₂ (K₂O₂: KPb = 3.3:2) in Ni-tubes (450°C; 17 d). The crystal structure (orthorhombic, space group Pbca with a = 658.2(1); b = 1 131.8(4); c = 1 872.2(6) pm; Z = 8) was refined (four-circle diffractometer data, Mo? K, 2 003 I_o(hkl), R = 4.9%, R_w = 2.8%). The Madelung Part of Lattice Energy (MAPLE), Effective Coordination Numbers (ECoN), the Mean Fictive Ionic Radii (MEFIR) and the Charge Distribution (CHARDI) are being calculated for both oxides.     

Synthesis and Structure of 5-Amino-6-(4-fluorophenylamino)-3-methylthio-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

The title compound (C18H15FN6OS) has been synthesized and its crystal structure was determined by X-ray analysis. The crystal belongs to monoclinic system, space group P21/n with a = 13.983(10), b = 7.337(5), c = 16.702(12) (A), α = 90, β = 98.277(12), γ = 90°, V = 1696(2)(A)3, Z = 4, Dc= 1.498 g/cm3, Mr = 382.42,μ = 0.224 mm-1, F(000) = 792, the final R = 0.0362 and wR = 0.0878 for 2579 observed reflections with I ＞ 2σ(Ⅰ). In the title compound, the atoms of C(1),C(2), C(3), C(4), C(5), N(1), N(2), N(3), N(4), N(5), N(6), O(1) and S(1) form a fully delocalized system with the average deviation of 0.0307(A). There exists a part of electron delocalization over the planes of Ⅰ (pyrazolo[3,4-d]pyrimidin-4-one moiety), Ⅱ (phenyl moiety) and Ⅲ (p-fluorophenylamine moiety). In the molecule, intermolecular hydrogen bonds between N(6)-H(6)…O(1)and C( 15)-H( 15)…O( 1 ) are observed.     

Synthesis,crystal structure,and density functional theory study of a new compound 4-(2-chlorobenzyl)-1-(5-fluoro-2-hydroxy-3-(thiomorpholinomethyl)phenyl [1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one

In this paper, a novel SHP244 derivative 4-(2-chlorobenzyl)-1- (5-fluoro-2-hydroxy-3- [thiomorph-olinomethyl] phenyl)- [1,2,4]triazolo [4,3-a] quinazolin-5(4H)-one was synthesized through five steps. The single crystals were grown in a suitable solvent system (dichloromethane and methanol). Its structure was confirmed by ¹H NMR, ¹³C NMR spectroscopy, ESI-MS, m/z: 534.12[M-H] (MS), FT-IR, and X-ray single crystal diffraction. The crystal structure of the title compound was optimized by density functional theory (DFT) calculation. The crystal structure after X-ray single crystal diffraction was compared with the structure optimized by DFT calculation, and the result shows that the two structures are consistent. In order to explore certain physical and chemical properties, the frontier molecular orbital and molecular electrostatic potential of the title compound were analyzed. In addition, the docking of the title compound to the target protein was studied to understand the docking effect of the compound with the target protein.     

Synthesis and Crystal Structure of N-（1,3,4-Thiadiazol-2-yl）-1-[ 1-（6-chloropyridin-3- yl）methy]-5-methyl-lH-[1,2,3]triazol-4-carboxamide

The crystal structure of the title compound （C12H10ClN7OS, Mr= 335.78） has been determined by single-crystal X-ray diffraction. The crystal is of triclinic, space group Pi with a = 8.4093（11）, b = 9.4430（12）, c = 11.1454（14） A, α = 95.508（2）, β = 111.366（2）, γ = 115.259（2）°, V = 711.42（16） A3, Z = 2, Dc = 1.568 g/cm3, F（000） = 344, μ（MoKα） = 0.428 mm-1, the final R = 0.0476 and wR = 0.1243 for 2353 observed reflections （I 〉 2o（/））. The dihedral angles between the pyridine and triazole, thiazole and triazole, and pyridine and thiazole rings are 69.2（1）, 9.2（1） and 72.7（1）°, respectively. Intramolecular C（8）--H（8B）...O（1） and N（5）-H（5A）..-N（4） as well as intermolecular C（5）-H（5）...S（1）, C（3）-H（3）.,.N（6） and N（5）-H（5A）...N（1） hydrogen bonds together with weak C-H...Ir hydrogen-bonding and π-π stacking interactions contribute to the stability of the structure. There is also evidence for significant electron delocalization in the triazolyl system.     

N，N’-二[3-氯-5S-（l-孟氧基）-2（5H）-4-呋喃酮基]-1，4-丁二胺的合成及晶体结构

合成了N,N’-二[3-氯-5S-（l-孟氧基）-2（5H）-4-呋喃酮基]-1,4-丁二胺,并通过IR,^1H NMR,MS和X射线单晶衍射对其进行了表征．X射线单晶衍射结果表明：标题化合物的不对称结构单元中包含一个平面的呋喃酮环和一个椅式的环己烷环,四个手性中心．标题化合物通过N—H…O分子间氢键作用实现空间堆积．     

10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮的合成和晶体结构

利用L-脯氨酸催化的5-氯水杨醛(1)与6-甲基-4-羟基吡喃酮(2)的缩合反应及硫酸铜催化下与1,3-二甲基-5-氨基吡唑(3)的串联反应,合成得到了10-氯-1,3-二甲基-5-(2-氧代丙基)色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(4)和10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(5).化合物5的结构通过单晶X射线衍射法确定:晶体属于三斜晶系,空间群P-1;相对分子质量Mr=803.68;晶胞参数a=1.03160(10)nm,b=1.42900(13)nm,c=1.44268(15)nm;V=1.9448(3)nm~3;Z=2;晶胞密度Dc=1.372g/cm~3;吸收系数μ=0.228mm-1;单胞中电子的数目F(000)=840.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0681,w R=0.2051.在晶体结构中色烯环与吡啶环及吡唑环近似于共平面.     

含硅铁键环状化合物[Me2Si-η5-C5H4Fe(CO)(PPh3)][Me2Si-η5-C5H4Fe- (CO)2－n(PPh3)n] (n＝0或1)的合成与结构

鉴于含硅-过渡金属键化合物作为催化剂具有重要的应用价值, 在我们最近发现的化合物(η⁵,η⁵-C₅H₄Me₂SiSi-Me₂C₅H₄)Fe₂(CO)₄ (1)的硅硅键和铁铁键复分解重排反应可以有效地合成含有两个硅铁键的环状化合物[Me₂Si-η⁵-C₅H₄- Fe(CO)₂]₂ (2)的基础上, 对该硅铁键环状化合物的三苯基膦取代衍生物[Me₂Si-η⁵-C₅H₄-Fe(CO)(PPh₃)][Me₂Si-η⁵-C₅H₄Fe(CO)_2－n(PPh₃)_n] (3: n＝0, 5: n＝1)的合成方法进行了研究. 发现化合物1在三苯基膦存在下的复分解重排反应是合成单三苯基膦取代产物3的最好方法; 而双三苯基膦取代化合物5则可通过光照条件下2与三苯基膦发生羰基取代反应而得到, 产物中含有的顺反异构体可利用制备薄层色谱法分离. 利用X射线衍射法测定了化合物3的分子结构, 考察了三苯基膦配体的存在对分子结构的影响以及三苯基膦与铁形成的配位键的稳定性.     

Synthesis, spectral characteristics, and crystal structure of the hexanuclear complex MeSi[η1,η5-C5H4(CO)2Fe(η1,η5-C5H5)Mn(CO)3]3

The reaction of MeSiCl₃ with 3 equivalents of LiC₅H₄(CO)₂Fe(η¹,η⁵-C₅H₄)Mn(CO)₃ afforded the hexanuclear complex MeSi[η¹,η⁵-C₅H₄(CO)₂Fe(η¹,η⁵-C₅H₅)Mn(CO)₃]3. The structure of the resulting complex was established by¹H and¹³C NMR and IR spectroscopy and by X-ray diffraction analysis. Dedicated to the memory of Academician M. I. Kabachnik on his 90th birthday. Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 10, pp. 2056–2061, October, 1998.     

Synthesis and Crystal Structure of Spiro[1-bromo(S)-4-(R)-hydroxy- 5-oxa-6-oxo-bicyclo[3.1.0]hexane-2,2''-(3''-diethyl-(-(S)-4''-Cl-benzyloxyphosphonyl-4''-(1R,2S,5R)-menthyloxybutyrolactone)]

The title compound, spiro[1-bromo(S)-4-(R)-hydroxy-5-oxa-6-oxo-bicyclo[3.1.0]-hxane-2,2'-(3'-diethyl-α-(S)-4'-Cl-benzyloxyphosphonyl-4'-(1R,2S,5R)-menthyloxybutyrolactone)] has been synthesized via the tandem asymmetric reaction and it crystallizes in a monoclinic system, space group P21 with a = 11.067(3), b = 12.484(2), c = 12.356(2)(A), β = 101.95°,C29H39BrC1O10P, Mr = 693.93, V= 1670.2(6) (A)3, Z= 2, Dc= 1.380 g/cm3, λ(MoKα) = 0.071073nm, μ = 1.410 mm-1, F(000) = 720, the final R = 0.0570 and wR = 0.0758 for 6190 observed reflections with I ＞ 2σ(I). The structure is characterized by the special combination of biologic phosphonyl group and one cyclopropane as well as two butyrolactones. The intermolecular hydrogen bond between O(3)-H(3A)…O(10) in the crystal lattice has been observed.     

Synthesis and Crystal Structure of N-[(3aR,4R,4aR,5aS,6S,6aS)-1,3-Dioxooctahydro-4,6-ethenocyclopropa[f]isoindol-2(1H)yl]-4-(trifiuoromethyl)phenylmethanimine Monohydrate

The crystal structure of the title compound (C19H17F3N2O4,Mr=394.35) was determined by single-crystal X-ray diffraction.The crystal belongs to monoclinic,space group C2/c with a=28.383(6),b=10.355(2),c=12.799(3)(A),β=111.74(3)°,V=3493.8(12)(A)3,Z=8,De=1.499 g/cm3,λ(MoKα)=0.71073,F(000)=1632,μ= 0.127 mm-1,R=0.0412 and wR=0.1019.In the title compound,there exist three intennolecular hydrogen interactions (O(4)...O(1),O(4)...O(3) and O(4)...N(1)) between water.The neighboring molecules are linked to each other generating a two-dimensional network structure via the three intermolecular hydrogen bonds and π-π interactions shaped by phen-phen with centroid distance of 4.049 (A).     

Synthesis, spectroscopic characterization, X-ray structure and DFT studies on 4-(2-hydroxyphenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium chloride hydrate

The title molecular salt, 4-(2-hydroxyphenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium chloride hydrate (C₁₂H₁₄N₃O⁺·Clˉ·H₂O), was synthesized and characterized by IR-NMR spectroscopy and single-crystal X-ray diffraction. In addition to the molecular geometry from X-ray experiment, the molecular geometry, vibrational frequencies and gauge-independent atomic orbital (GIAO) ¹H and ¹³C NMR chemical shift values of the title compound in the ground state have been calculated using the density functional theory (DFT/B3LYP) method with the 6-31++G(d,p) and 6-311++G(d,p) basis sets, and compared with the experimental data. Besides, molecular electrostatic potential (MEP) distribution and non-linear optical properties of the title compound were investigated by theoretical calculations at the B3LYP/6-311++G(d,p) level.     

Synthesis and Crystal Structure of 7-Amino-2,3,4,5-tetrahydro- 1,3-dimethyl- 5-（2-nitrophenyl）-2,4-dioxo-lH-pyrano[2,3- d]pyrimidine-6-carbonitrile DMF Solvate

The title compound 7-amino-2,3,4,5-tetrahydro-1,3-dimethyl-5-（2-nitrophenyl）- 2,4- dioxo-1H-pyrano[2,3-d] pyrirnidine-6-carbonitrile DMF solvate 1 （C19H20N6O6, Mr = 428.41） was synthesized and crystallized. The crystal belongs to the monoclinic system, space group P2 1/c with a = 11.383（2）, b = 13.372（2）, c = 13.673（2）A, β = 97.380（4）°, Z = 4, V = 2063.8（6）A^3, Dc = 1.379 g/cm^3,μ（MoKα） = 0.105 mm^-1, F（000） = 896, the final R = 0.0738 and wR = 0.1647 for 2964 observed reflections （I〉 2σ（I））. X-ray analysis reveals that the new pyran ring is coplanar, which is obviously different from those of other similar compounds. In addition, the unclassical hydrogen bonds of C-H…O and C-H…N are presented in the crystals except for the normal hydrogen bonds of N-H…O.     

Synthesis and Crystal Structure of 3,7,7-Trimethyl- 1-phenyl-4-（3-nitrophenyl）- 4,5,6,7,8,9-hexahydro-1H-pyrazolo [3,4-b]quinoline-5（6H）-one

The title compound (C25H24N4O3) has been prepared by the cyclocondensation of 5-amino-3-methyl-l-phenypyrazol, m-nitrobenaldehyde and dimedone in glycol under microwave irradiation without catalyst. The crystal structure was determined by single-crystal X-ray diffraction to be orthorhombic, space group Pbca with a=16.3331(10), b=13.8329(9), c=19.4163(12) A, V= 4386.8(5)A3, Z=8, Dc=1.298g/cm^3,μ=0.087 mm^-1, F(000)=1808, Mr=428.48, the final R=0.0519 and wR=0.1019. X-ray analysis revealed that the pyridine ring is of boat conformation and the six-membered ring fused with it adopts twist boat conformation.     

Synthesis and characterization of nickel and copper complexes with 2,2-diphenyl- N -(alkyl(aryl)carbamothioyl)acetamide: The crystal structures of HL1 and cis -[Ni(L1)2]

2,2-diphenyl-N-(R-carbamothioyl)acetamide (R = diethyl, dipropyl, dibutyl, dihexyl, diphenyl and morpholine-4) and their Ni²⁺ and Cu²⁺ complexes have been synthesized and characterized by elemental analyses, IR spectroscopy and ¹H-NMR spectroscopy. The spectroscopic data are consistent with the ligand and the metal complexes containing two O, S chelated ligands. 2,2-diphenyl-N-(diethylcarbamothioyl)acetamide, HL¹, and bis(2,2-diphenyl-N-(diethylcarbamothioyl)acetamido)nickel(II), Ni(L¹)₂, were characterized by a single crystal X-ray diffraction study. HL¹ complex, C₁₉H₂₂N₂OS, crystallizes monoclinic, space group P2₁/c, with Z = 4, and unit cell parameters a = 14.964(2), b = 13.026(2), c = 9.0123(15) Å, β = 96.314(4)°. Ni(L¹)₂ complex, C₃₈H₄₂N₄O₂S₂Ni, crystallizes in monoclinic space group P2₁/c, with Z = 4, and unit cell parameters a = 15.434(6), b = 13.464(5), c = 17.679(7) Å, β = 108.477(11)°. The ligands coordinate bidentate to metal yielding neutral complexes of the type cis-[ML₂].     

Synthesis and Crystal Structure of 4-（2-Chlorophenyl）-5-cyano-3-methyl-6-oxo-1-phenyl-4,5,6,7-tetrahydropyrazolo[3,4-b]Pyridine under Microwave Irradiation

1 INTRODUCTION The pyrazolo[3,4-b]pyridine system has many interesting biological and pharmacological proper- ties, such as active antitubercular agents[1, 2], active agents against gram positive and negative bacteria[3], ACTH(Adrenocorticotropic hormone…     

Synthesis,characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex,Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2

Cadmium chloride complex of 1-furoyl-3-cyclohexylthiourea (CyTu) was prepared and characterized by elemental analysis, IR, and Raman spectroscopy. The structure of the complex was determined by single crystal X-ray methods (space group Bbab, a = 20.918(1), b = 23.532(1), c = 23.571(1) Å, α = β = γ, Z = 8). Each cadmium has distorted octahedral geometry, coordinated by two chlorides and the thiocarbonyl sulfurs from four CyTu molecules. All the spectroscopic data are consistent with coordination of CyTu by sulfur to cadmium.     

Synthesis, Crystal Structure and Fungicidal Activity of 3- ( 4- Chloro- 3- ethyl- 1 -methyl- 1 H- pyrazol- 5-yl ) - 6- (E) phenylvinyltriazolo [ 3, 4-b ] - 1,3, 4-thiadiazole

1　ＩＮＴＲＯＤＵＣＴＩＯＮＩｎｒｅｃｅｎｔｙｅａｒｓ ,ｔｒｉａｚｏｌｏ[3,4, ｂ] 1 ,3,4 ｔｈｉａｄｉａｚｏｌｅｄｅｒｉｖａｔｉｖｅｓｈａｖｅｂｅｅｎａｔ ｔｒａｃｔｉｎｇｍｕｃｈａｔｔｅｎｔｉｏｎｆｒｏｍｃｈｅｍｉｓｔｓａｎｄｐｈａｒｍａｃｏｌｏｇｉｓｔｓｂｅｃａｕｓｅｔｈｅｙｓｈｏｗｂｒｏａｄｓｐｅｃｔｒａｏｆｂｉｏｌｏｇｉｃａｌａｃｔｉｖｉｔｉｅｓ,ｓｕｃｈａｓｉｎｓｅｃｔｉｃｉｄａｌ[1 ] ,ａｎｔｉｆｕｎｇａｌ[2 ] ,ｈｅｒｂｉｃｉｄａｌ[3] ,ａｎ ｔｉｂａｃｔｅｒｉａｌ[4] ,ｈｙｐｏｔｅｎｓｉｖ…     

Synthesis and multinuclear NMR study of Hg(II), Cd(II), and Pd(II) complexes with biphenylmethylenetriphenylphosphorane: X-ray crystal structure of [{C6H5C6H4CO{(C6H5)3P}CH}HgI2]2

Reactions of title ylide, {(C₆H₅)₃PCHCOC₆H₄C₆H₅)} (BPPPY), with mercury(II) halides in equimolar ratios in methanol yielded dinuclear complexes [(BPPPY)HgCl₂]₂ (1), [(BPPPY)HgBr₂]₂ (2), and [(BPPPY)HgI₂]₂ (3). Reactions of BPPPY with CdCl₂ in equimolar ratios gave [(BPPPY)CdCl₂]₂ (4). Reaction of PdCl₂ with BPPPY (1/2) in acetonitrile at room temperature gave cis/trans [PdCl₂{CH(PPh₃)COC₆H₄C₆H₅}₂] (5). The same reaction at reflux gave the orthopalladated complex [Pd{CH{P(2-C₆H₄)Ph}(COC₆H₄C₆H₅)}(μ-Cl)]₂ (6) along with the phosphonium salt [Ph₃PCHCOC₆H₄C₆H₅]Br. The compounds were characterized by elemental analysis, IR-, ¹H-, ¹³C-, and ³¹P-NMR spectroscopy. Single crystal X-ray analysis of 3 reveals the centrosymmetric dimeric structure containing the ylide and HgI₂. Crystallographic data for 3 are: crystal system, monoclinic; space group, P 2₁/n, a = 15.7744(7), b = 23.0288(9), c = 20.2867(9) Å, β = 112.237(3)°, V = 6821.4(5) ų, and Z = 1.     

Synthesis,structural characterization and in vitro antitumour properties of triorganoantimony(V) disalicylates: Crystal and molecular structures of [5-Y-2-(ho)-C6H3COO]2SbMe3 (YH,Me, MeO)

Triorganoantimony(V) salicylates, [5-Y-2-(HO)-C₆H₃COO]₂SbR₃ (R=Me, Ph; Y=H, Me, MeO), were obtained by reacting R₃SbCl₂ with the appropriate sodium salt. The compounds have been characterized by IR, MS, ¹H and ¹³C NMR spectroscopy. The molecular structure of the three substituted trimethylantimony(V) disalicylates has been determined by X-ray diffraction. The salicylate ligands are mono-coordinated to antimony through an oxygen atom of each carboxylate, leading to a trigonal bipyramidal geometry, with the antimony-methyl groups in equatorial positions and the oxygen atoms in axial positions. The trimethylantimony compounds tested in vitro against a series of human tumour cell lines were found to be inactive.